Inventor · disambiguated record
Marcin Stasiak
Also filed as: STASIAK MARCIN
20 granted patents·6 pending applications·334 citations·filing 1998–2015
94Inventor score
Top patents by PatentIndex Score
26 records- 0195US6265422B1Bicyclic inhibitors of protein farnesyl transferaseWARNER LAMBERT CO·Filed 2000·Granted Jul 24, 2001·53 cites·40 claims
- 0294US6413963B2Reverse-turn mimetics and methods relating theretoMOLECUMETICS LTD·Filed 2000·Granted Jul 2, 2002·55 cites·19 claims
- 0391US9643130B2Hydrophilically modified fluorinated membrane (IV)PALL CORP·Filed 2015·Granted May 9, 2017·3 cites·11 claims
- 0491US6440955B1Reverse-turn mimetics and methods relating theretoMOLECUMETICS LTD·Filed 2001·Granted Aug 27, 2002·35 cites·18 claims
- 0591US6133303ABicyclic inhibitors of protein farnesyl transferaseWARNER LAMBERT CO·Filed 1998·Granted Oct 17, 2000·50 cites·9 claims
- 0690US6548500B2Reverse-turn mimetics and methods relating theretoMOLECUMETICS LTD·Filed 2000·Granted Apr 15, 2003·29 cites·20 claims
- 0789US6184223B1Reverse-turn mimetics and methods relating theretoMOLECUMETICS LTD·Filed 1999·Granted Feb 6, 2001·61 cites·22 claims
- 0887US9643131B2Hydrophilic porous polytetrafluoroethylene membrane (I)PALL CORP·Filed 2015·Granted May 9, 2017·2 cites·7 claims
- 0985US9724649B2Self-wetting porous membranes (I)PALL CORP·Filed 2015·Granted Aug 8, 2017·2 cites·20 claims
- 1079US6294525B1Reverse-turn mimetics and methods relating theretoMOLECUMETICS LTD·Filed 1999·Granted Sep 25, 2001·35 cites·24 claims
- 1177US9649603B2Hydrophilically modified fluorinated membrane (III)PALL CORP·Filed 2015·Granted May 16, 2017·1 cites·15 claims
- 1274US6528535B2Bicyclic inhibitors of protein farnesyl transferaseWARNER LAMBERT CO·Filed 2001·Granted Mar 4, 2003·5 cites·18 claims
- 1371US10239023B2Self-wetting porous membranes (II)PALL CORP·Filed 2015·Granted Mar 26, 2019·1 cites·17 claims
- 1468US7598253B2Reverse-turn mimetics and methods relating theretoMYRIAD GENETICS INC·Filed 2003·Granted Oct 6, 2009·2 cites·23 claims
- 1551US10315168B2Hydrophilic porous polytetrafluoroethylene membrane (II)PALL CORP·Filed 2015·Granted Jun 11, 2019·0 cites·10 claims
- 1651US9849428B2Hydrophilically modified fluorinated membrane (VI)PALL CORP·Filed 2015·Granted Dec 26, 2017·0 cites·20 claims
- 1751US2003130168A1Reverse-turn mimetics and methods relating theretoMOLECUMETICS LTD·Filed 2002·Application pending·0 cites
- 1848US2009318396A1Corticosteroid linked beta-agonist compounds for use in therapyGILEAD SCIENCES INC·Filed 2009·Application pending·0 cites
- 1947US2010112061A1Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic BronchitisBAKER WILLIAM·Filed 2007·Application pending·0 cites
- 2047US2013012504A1Bi-functional quinoline analogsGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 2147US2010098641A1Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and BronchoconstrictionBAKER WILLIAM·Filed 2007·Application pending·0 cites
- 2246US8367829B2Bi-functional pyrazolopyridine compoundsGILEAD SCIENCES INC·Filed 2011·Granted Feb 5, 2013·0 cites·18 claims
- 2343US8450490B2Bi-functional pyrazolopyridine compoundsBAKER WILLIAM R·Filed 2012·Granted May 28, 2013·0 cites·4 claims
- 2443US2010209508A1Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and BronchoconstrictionCORUS PHARMA INC·Filed 2006·Application pending·0 cites
- 2540US7345040B2Reverse-turn mimetics and compositions and methods relating theretoMYRIAD GENETICS INC·Filed 2005·Granted Mar 18, 2008·0 cites·65 claims
- 2639US8394829B2Bi-functional quinoline analogsBAKER WILLIAM R·Filed 2011·Granted Mar 12, 2013·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Marcin Stasiak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →